HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    
What's Up With These Ridiculous Stock Gains?

Steve Reitmeister didn't want me to tell you this. He felt that one strategy's performance stands out so much that... Read on >>
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive

ACHN: Achillion Pharmaceuticals Inc - Detailed Stock Quote Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Quote |  Detailed Quotes |  Real Time |  Options Chain |  Greeks Montage
ACHILLION PHARMACEUTICALS INC (NASD)
ACHN 1.87 N/A (N/A%) Vol.  0 N/A ET
Last 1.87 Bid / Size 1.60x100
Net  N/A Ask / Size N/A
% Change  N/A 52 Wk High 2.42
High N/A 52 Wk Low 0.65
Low N/A Volume 0
 
Insider Ownership 34.84% S&P 500 Member NO
Institutional Ownership 16.3% Beta -.28
P/E (TTM) PEG Ratio
PE (forward) Price / Sales 34.54
 
Dividend N/A
Dividend Yield 0
Last Dividend Date N/A
5 Year Avg. Yield 0
Dividend Payout Ratio
 
Shares Outstanding 26,656,000
Market Capitalization 49,846,720
Last Split Date N/A
Split Factor N/A
Short Interest Ratio 1.42
 
% Change
4 Weeks 1.07
12 Weeks -1.06
52 Weeks 86.99
 
% Change Relative to S&P 500
4 Weeks -1.36
12 Weeks -7.98
52 Weeks 35.23

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research